FILE PHOTO: A syringe with a dose of the AstraZeneca vaccine against the coronavirus disease (COVID-19) is seen in a vaccination centre at the Cecchignola military compound, in Rome, Italy, March 9, 2021. REUTERS/Guglielmo Mangiapane
ROME (Reuters) - When alarm about potential side effects of AstraZeneca's COVID-19 shot halted vaccinations around Europe this month, many people worried this would damage public trust in the vaccine. In Italy, legal action has added to the turbulence.
On March 11, a prosecutor in the Sicilian city of Syracuse placed two doctors and a nurse under investigation for possible manslaughter, following the sudden death of a navy officer just hours after he had received the shot made by AstraZeneca PLC.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
